Men and women may yield different consequences based on dose, route, and biology
Balenovic D, Bencic ML, Udovicic M, et al
Currently, the BPC-157 peptide is not FDA-approved, and research is ongoing regarding its medical applications
Serious side effects of the medication include the following: Allergic or hypersensitivity reaction Severe gastrointestinal issues Changes in mood and behavior Pancreatitis Liver problems Low blood sugar levels (hypoglycemia) Cardiac arrhythmias Suicidal ideation Major depressive disorder No adverse event of hypoglycemia or thyroid cancer was reported in Phase II trials, and 7% of retatrutide participants had skin sensitivity, compared to 1% on placebo, but these cases were not serious
Leah K.Verified PurchaseMar 15, 2026 Five weeks in and friends have asked what I am doing differently